Publication | Open Access

Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

VaccinationHvtn 503/PhambiliHuman RetrovirusSouth AfricaClade-b-based Hiv-1 VaccineVaccine TrialAntiviral TherapyVaccine TestingVaccine EfficacyHivMedicineEpidemiology